# Science Translational Medicine

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Science Translational Medicine is a premier scientific journal focused on translational medicine, published by the American Association for the Advancement of Science (AAAS). It serves as a platform for authors, reviewers, and advisors in the scientific community to submit, review, and manage manuscripts.

- Business Profile: https://optimly.ai/brand/science-translational-medicine
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://cts.sciencemag.org/
- Logo: https://logo.clearbit.com/cts.sciencemag.org
- Slug: science-translational-medicine
- Brand Authority Index tier: Emerging
- Archetype: Incumbent
- Category: Academic Publishing
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: Traditional mail/email submissions: Relying on physical mail or unstructured email for manuscript submissions, reviews, and communications, leading to significant delays and organizational challenges. | Specialized publishing services: Engaging third-party agencies or university presses to manage the entire publication process, potentially incurring higher costs and less direct control over the journ | Not publishing research: Foregoing formal peer-reviewed publication of research, which would severely limit dissemination, credibility, and impact within the scientific community.
Solutions: Science Translational Medicine journal | submit manuscript Science Translational Medicine | AAAS translational medicine journal | General academic publishing software: Utilizing generic or less specialized manuscript management systems that may lack the specific features or prestige associated with the 'Science Content Tracking